It is widely accepted that chronic inflammation contributes to the pathogenesis of obesity. Researchers have recently discovered that increased inflammatory cytokines and the infiltration and activation of macrophage cells in the adipose tissue are related to chronic obesity. This immunologic dysregulation has led to the development of the classical pro-inflammatory paradigm. However, since chronic inflammation associated with obesity is more than just the overproduction of pro-inflammatory cytokines, precise dissection requires beyond the classical pro-inflammatory cytokines.
INTRODUCTION
Obesity, which involves chronic low-grade inflammation, has become a global epidemic. This poses a large health burden, because excess adiposity can lead to an array of chronic diseases such as type 2 diabetes, stroke, coronary heart disease and high blood pressure [1] . Obesity is associated with an abnormal increase in adipose tissue mass and liver fat (adiposity), as well as dysregulated levels of adipocytokines and imbalance of T helper cell type-1 (Th1) and Th2 cytokines [2] . It is well-established that the inflammatory response associated with obesity is triggered by and predominantly resides in the adipose tissue [3] . Adipose tissue is a biologically-active endocrine tissue that serves as energy storage and secretes various adipocytokines such as adiponectin, leptin, tumor necrosis factor-α (TNF-α), resistin and plasminogen-activator type 1 (PAI-1) [4] [5] [6] [7] [8] . Of these adipokines, adiponectin and leptin are novel specific hormones implicated in the pathogenesis of obesity [4] . The immunological profiling of obesity-related biomarkers will allow researchers to better understand the complex interactions between classical immunocytes, adipose tissue macrophages, adipokines and other inflammation-related cytokines implicated in the pathogenesis of chronic low-grade obesity. In summary, this review will highlight the importance of adipokines and the Th1 and Th2 network in obesity.
IMMUNE FEATURES OF OBESITY
There is some controversy surrounding the immune features of obese and non-obese states. The host defense immune response mechanism comprises innate and adaptive immunity. According to Lumeng and Saltiel, "the chronic nature of obesity produces a tonic low-grade activation of the innate system that affects metabolic homeostasis over time" [9] . Obesity triggers an immune response that includes a systemic increase in circulating inflammatory cytokines, the recruitment of immunocytes to inflamed tissues, activa-
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Medicine tion of leukocytes, and the generation of repair tissue responses [10] . Thus, it seems feasible that alterations in immune function induced by obesity would be mirrored through immunological parameters such as leucocyte and lymphocyte subpopulation counts and the secretion of cytokines and adipokines. However, the weaker nature of chronic inflammation such as obesity is often difficult to detect the exact immunologic status, thereby ignoring the serious systemic complications, which would be ascribed to the immunologic dysfunction. as leptin, and decreased secretion of anti-inflammatory proteins such as adiponectin [11] . Of these adipokines, researchers have extensively studied the role of the leptin in obesity. Leptin circulates in blood serum and regulates energy intake and expenditure [12] . Starvation conditions trigger a decrease in leptin levels, leading to neural pathways in the hypothalamus that cause increased appetite and decreased energy expenditure, as a means of restoring body fat [13, 14] . However, in the obese state, where there is an accumulation of fat, leptin plasma levels increase. Other studies also showed that mice lacking leptin or the leptin receptor were severely obese [15] [16] [17] . Leptin can be regarded as a cytokine, since the leptin receptor bears significant homology to type 1 cytokine receptors [18] . Leptin is now considered the master hormone for long-term body weight control [19] . In the obese state, immunocytes are subject to higher circulating leptin concentrations, innate immunity is activated, and there is a predominance of pro-inflammatory Th1 cells and reduced Th2 phenotypes [20] . This pro-inflammatory phenotype switch is beneficial during acute infections. Paradoxically, over the long-term and in chronic conditions, it would be deleterious.
OBESITY AND ADIPOKINES
Adiponectin is another adipokine that contributes to the chronic low-grade inflammation associated with obesity.
Adiponectin, abundantly present in the plasma, is known to modulate metabolic processes and increase insulin sensitivity through regulation of glucose metabolism and induction of fatty acid oxidation [21] . Plasma concentrations of adiponectin decrease with increasing obesity. Convincing evidences showed that overexpression of the adiponectin gene would protect the mice from diabetes and atherosclerosis [22] . Adiponectin is known to enhance IL-10 mRNA expression, thereby augmenting IL-10 release from macrophages [23] . In addition, overexpression of adiponectin leads to differentiation of 3T3-L1 fibroblasts to adipocytes via metabolic effects in an autocrine fashion [24] , which also has been proven by another study in vivo [25] . Herein, the important point is that imbalances in the cytokine and adipokine network would affect the inflammatory status of obesity or metabolic syndrome. This is greatly indebted to new concept of immune homeostasis beyond classical immune homeostasis.
IMMUNOLOGIC ACTIVATION BEYOND THE CLASSICAL PROINFLAMMATORY PARADIGM
Chronic inflammation in obesity would more aggravate the inflamed visceral adipose tissue brought via the accumulation of inflammatory immunocytes such as T cells, as well as the activation of macrophages, consequently, leading to the overproduction of pro-inflammatory cytokines [26] .
Obesity is associated with moderate but chronic production of these inflammatory factors [27] .
In the point of innate immunology, obesity is widely characterized by macrophage infiltration into the adipose tissue. This tissue-resident macrophage has two different phenotypes: M1 (pro-inflammatory) and M2 (anti-inflammatory) [28] [29] [30] [31] . Chronic obesity involves the accumulation of M1-polarized macrophages [29] [30] [31] and a switch from the M2 to the M1 phenotype. That is, chronic obesity leads to a more pro-inflammatory profile (Fig. 1 ) [28] . Thus, the absence of the anti-inflammatory macrophage response is linked to a higher risk of obesity, inflammation and insulin resistance [32] . The M1/M2 polarization paradigm describes the macrophage activation directed against pro-inflammatory M1 driven by the Th-1 type cytokine such as interferon-gamma (IFN-γ) (Fig. 1 ) [33] . This "phenotype switch" from M2 to M1 made it plausible that T cells and and the development of insulin resistance implicated in obe-sity [27] . Consistent study demonstrated that neutralization of TNF-α with a TNF-α soluble antibody resulted in improved insulin sensitivity in an obese mouse model [36] .
TNF-α was also found to augment the release of pro-inflammatory cytokines such as IL-6 and IL-1β in a paracrine fashion [37] . Higher circulating levels of TNF-α and IL-6 are found in overweight pediatric populations [29] [30] [31] [38] [39] [40] . The pleiotropic IL-6 cytokine is associated with regulation of weight gain, which is supported by the finding that deletion of the IL-6 gene in mice led to mature-onset obesity [41] . Since obesity is associated with increased production of TNF-α and IL-6, inhibiting the expression and release of these cytokines might help treat cytokine imbalances found in obesity. Another important pro-inflammatory cytokine with increased expression in obesity is monocyte chemo-attractant protein (MCP)-1, which contributes to insulin resistance and macrophage infiltration [42] . IL-4, a Th2-type cytokine, has marked inhibitory effects on the expression and release of pro-inflammatory cytokines such as TNF-α, IL-6 and IL-8 [43] . Another potent anti-inflammatory Th-2 type cytokine is IL-10, which is primarily synthesized by CD4+ Th2 cells, monocytes and B cells [44, 45] , and has a strong inhibitory effect against Th1 cytokines. Several lines of evidence have verified the beneficial effect of the gain and loss of IL-10 function on infectious and inflammatory-related diseases [46] [47] [48] [49] [50] [51] . IL-13, which is secreted by activated T lymphocytes [52] , is an additional anti-inflammatory cytokine that has been mapped in proximity to the IL-4 gene and down-regulates TNF-α, IL-1 and IL-8 [53, 54] . Given these, IL-4, IL-10, and IL-13 might be a potential anti-inflammatory therapies against chronic low-grade obesity. The veiled roles of these anti-inflammatory cytokines in clinical medicine remain to be elucidated.
IMMUNOASSAY OF OBESITY BIOMARKERS
It has been well-documented that important adipokine bio- 
